Genotyping and serotyping of macrolide and multidrug resistant Streptococcus pneumoniae isolated from carrier

S F Swedan1, W A Hayajneh, G N Bshara

  • 1Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.

Insights

A high percentage of young children carry drug-resistant Streptococcus pneumoniae, with macrolide resistance prevalent. This highlights the urgent need to address antimicrobial resistance in pediatric populations.

Area of Science:

  • Microbiology
  • Pediatrics
  • Infectious Diseases

Background:

  • Streptococcus pneumoniae is a common cause of childhood infections and is increasingly resistant to antibiotics.
  • Understanding carriage rates, serotypes, and resistance mechanisms is crucial for public health.

Purpose of the Study:

  • To investigate Streptococcus pneumoniae carriage in children under 5.
  • To identify prevalent serotypes and antimicrobial resistance patterns, particularly to macrolides.
  • To determine the genetic basis of macrolide resistance.

Main Methods:

  • Collected nasopharyngeal swabs from 157 children under 5.
  • Performed cultural isolation and antimicrobial susceptibility testing (disk diffusion, E-test).
  • Identified serotypes and macrolide resistance genes (erm(B), mef(E)) using multiplex PCR.

Main Results:

  • S. pneumoniae was carried by 33.8% of children, with higher rates in males.
  • Prevalent serotypes included 19F, 6A/B, 11A, 19A, 14, and 15B/C.
  • Macrolide resistance was 60.4%, often coexisting with resistance to other antibiotics. erm(B) and mef(E) genes were identified in resistant isolates.

Conclusions:

  • A significant proportion of children carry multidrug-resistant S. pneumoniae.
  • The study identifies key serotypes and resistance genes contributing to antimicrobial resistance in children.
  • Findings underscore the public health challenge posed by resistant S. pneumoniae in pediatric populations.
Abstract

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
13
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
44
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
10